- Home
- FBRX vs SCNX Comparison
FBRX vs SCNX Comparison
Compare FBRX & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- SCNX
- Stock Information
- Founded
- FBRX N/A
- SCNX 2010
- Country
- FBRX United States
- SCNX United States
- Employees
- FBRX N/A
- SCNX N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- FBRX Health Care
- SCNX Health Care
- Exchange
- FBRX Nasdaq
- SCNX Nasdaq
- Market Cap
- FBRX 35.3M
- SCNX 33.6M
- IPO Year
- FBRX N/A
- SCNX 2020
- Fundamental
- Price
- FBRX $7.35
- SCNX $1.24
- Analyst Decision
- FBRX Strong Buy
- SCNX
- Analyst Count
- FBRX 4
- SCNX 0
- Target Price
- FBRX $76.58
- SCNX N/A
- AVG Volume (30 Days)
- FBRX 54.6K
- SCNX 8.6M
- Earning Date
- FBRX 05-12-2025
- SCNX 05-10-2025
- Dividend Yield
- FBRX N/A
- SCNX N/A
- EPS Growth
- FBRX N/A
- SCNX N/A
- EPS
- FBRX N/A
- SCNX 2.68
- Revenue
- FBRX N/A
- SCNX $136,643.00
- Revenue This Year
- FBRX N/A
- SCNX N/A
- Revenue Next Year
- FBRX N/A
- SCNX N/A
- P/E Ratio
- FBRX N/A
- SCNX $1.69
- Revenue Growth
- FBRX N/A
- SCNX N/A
- 52 Week Low
- FBRX $4.11
- SCNX $1.00
- 52 Week High
- FBRX $28.68
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- FBRX 44.84
- SCNX N/A
- Support Level
- FBRX $7.10
- SCNX N/A
- Resistance Level
- FBRX $9.04
- SCNX N/A
- Average True Range (ATR)
- FBRX 1.32
- SCNX 0.00
- MACD
- FBRX 0.34
- SCNX 0.00
- Stochastic Oscillator
- FBRX 50.62
- SCNX 0.00
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.